Cancer & Immunotheraphy

 

 

With so much activity around cancer vaccines and immunotherapy right now, can you afford to miss out? It is the place where the global market will come together to share the latest in early-stage scientific advancements, present clinical trial data, discuss new formulations of cancer vaccines and assess the future of combination treatments. Make sure that people are aware of the work you are doing to put yourself at the forefront of the industry.

 

Who Attends

 

• Pharma
• Biotech
• National and International Government
• Non-Profit Organizations
• Academics And Research Institutions

 

Job Titles

 

• CEO / CSO / COO
• CMO / Head of Scientific Affairs
• Head of Oncology
• Head of Immuno-Oncology/ Immunotherapy
• Head of R&D

Who Should Sponsor?

 

• Platform Technology Providers
• Biotechs
• Big Pharma

 

 

Cancer & Immunotherapy Vaccines Conference, Tuesday 16 April 2019

Cancer & Immunotherapy Vaccines Conference
09:00

Chair's opening remarks

Novel Immunotherapy Trends

Dr Pramod Srivastava
Cancer & Immunotherapy Vaccines Conference
10:10

Novel approaches to neoantigen identification lead to first ever genomics-driven personalized medicine clinical trial of ovarian cancer

10:40

Networking Coffee Break

Dr Jessica Baker Flechtner
Cancer & Immunotherapy Vaccines Conference
11:40

Inhibitory T cell responses are identified using the ATLASTM platform technology: implications for cancer immunotherapy

Cancer vaccines

Dr David Anderson
Cancer & Immunotherapy Vaccines Conference
11:55

Virus like particles for effective antigen delivery in therapeutic vaccines

Dr Marit Van Buuren
Cancer & Immunotherapy Vaccines Conference
12:10

Overview of Neon’s approach to the development of personalized cancer immunotherapies

Dr Hari Pujar
Cancer & Immunotherapy Vaccines Conference
12:25

Updates in the early clinical development of mRNA-based personalized cancer vaccines

Linda Powers
Cancer & Immunotherapy Vaccines Conference
12:40

DCVax® Personalized Immune Therapies for Cancer

13:10

Networking Lunch & Poster Session

Dr Mansi Saxena
Cancer & Immunotherapy Vaccines Conference
14:40

Panel: Re-emergence of dendritic cell vaccines for cancer treatment

15:24

Oncolytic Viruses

Cancer & Immunotherapy Vaccines Conference
15:55

Late stage clinical development of adeno virus-based immunotherapy

Reserved
16:09

Networking Coffee Break

Dr Steve Thorne
Cancer & Immunotherapy Vaccines Conference
16:40

Vaccinia virus-based immunotherapy for the treatment of solid tumors

Checkpoints, targeted drugs and combinations

18:10

Chair’s Closing Remarks per co-lo and Close of Congress Day 2

18:15

Off-site Networking Drinks, follow the congress team

last published: 13/Dec/18 12:35

 

Cancer & Immunotherapy Vaccines Conference, Wednesday 17 April 2019

Cancer & Immunotherapy Vaccines Conference
09:00

Chair’s opening remarks

Engineered Cancer Immunotherapy: T cells to Bispecifics, and beyond

Dr Wayne Chu
Cancer & Immunotherapy Vaccines Conference
09:40

Anti CD20/CD3 T-cell-dependent bispecific antibodies for hematologic malignancies

Cancer & Immunotherapy Vaccines Conference
10:10

BCMA CAR-T Therapies for multiple myeloma

10:40

Networking Coffee Break

12:30

Networking Lunch & Poster Session

DAY 3 AFTERNOON PLENARY OF CONGRESS: RENAISSANCE BALLROOM

Paul Offit
Dr Saad Omer
14:55

A framework for a comprehensive maternal immunization platform

  • Evidence for current immunization recommendations
  • Maternal vaccines in development
  • The need for evidence-based interventions at the practice, provider, and patient levels to ensure higher vaccination levels
Dr Timothy Cooke
16:00

Chair Closing Remarks and End of Congress

last published: 13/Dec/18 12:35

Sign Up for Event Updates

Get Involved At World Vaccine Congress Washington

 

To Sponsor Or Exhibit

Marc Rhys-Evans
marc.rhys-evans@terrapinn.com
+44 20 7827 5945

 

 

 

To Register

Tayyab Abbasi
tayyab.abbasi@terrapinn.com
+44 20 7092 1210

 

 

 

Press Relations

Karina Kusova
karina.kusova@terrapinn.com
+44 20 7092 1071